Clinical manifestations are complex and often involve multiple systems. Early identification and normalisation of clinical trials are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation.
A team of authoritative experts at home and abroad can assist in providing accurate diagnosis and treatment. Treatment and management of CLD manifestations require individual development, usually including drug therapy, rehabilitation interventions, regular follow-up management, etc. In recent years, with the development of therapeutic, immune-regulated therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of CblD. The platform serves China International Medical Service System, a team of nationally and internationally authoritative experts in the field of genetic metabolism, who provide the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.